Supplemental Figure 1. Bias-corrected NGS bioinformatics strategies. Paired-end DNA sequencing reveals the sequence of the genomic clone, the sample ID.

Slides:



Advertisements
Similar presentations
Reference mapping and variant detection Peter Tsai Bioinformatics Institute, University of Auckland.
Advertisements

Genome-wide Association Study Focus on association between SNPs and traits Tendency – Larger and larger sample size – Use of more narrowly defined phenotypes(blood.
Transcriptome Sequencing with Reference
Immune profiling with high-throughput sequencing Harlan Robins 1,2 Cindy Desmarais 2, Chris Carlson 1,2 Fred Hutchinson Cancer Research Center, Seattle,
Variant discovery Different approaches: With or without a reference? With a reference – Limiting factors are CPU time and memory required – Crossbow –
Biology and Bioinformatics Gabor T. Marth Department of Biology, Boston College BI820 – Seminar in Quantitative and Computational Problems.
Whole Exome Sequencing for Variant Discovery and Prioritisation
Page 1 Mouse Genome CGH Microarray 44A. Page 2 Mouse Genome CGH Microarray Kit 44A Designed for CGH, Validated with samples of known aberrations Designed.
Assay Development Breakout (red) Who was in the room? About half of attendees are active NGS users N=1 doing whole genome analyses Everyone else doing.
Screening a Library Plate out library on nutrient agar in petri dishes. Up to 50,000 plaques or colonies per plate.
LOC_Os02g08480 Supplementary Figure S1. Exons shorter than a read length have few or no reads aligned. The gene at LOC_Os02g08040 contains exons shorter.
Chromatin Immunoprecipitation DNA Sequencing (ChIP-seq)
SIZE SELECT SHEAR Shotgun DNA Sequencing (Technology) DNA target sample LIGATE & CLONE Vector End Reads (Mates) SEQUENCE Primer.
HaloPlexHS Get to Know Your DNA. Every Single Fragment.
Identification of Copy Number Variants using Genome Graphs
RNA-Seq Primer Understanding the RNA-Seq evidence tracks on the GEP UCSC Genome Browser Wilson Leung08/2014.
ASSEMBLY AND ALIGNMENT-FREE METHOD OF PHYLOGENY RECONSTRUCTION FROM NGS DATA Huan Fan, Anthony R. Ives, Yann Surget-Groba and Charles H. Cannon.
Reliable Identification of Genomic Variants from RNA-seq Data Robert Piskol, Gokul Ramaswami, Jin Billy Li PRESENTED BY GAYATHRI RAJAN VINEELA GANGALAPUDI.
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Identification of a Novel TP53 Cancer Susceptibility.
Canadian Bioinformatics Workshops
Paul J. Norman, Jill A. Hollenbach, Neda Nemat-Gorgani, Wesley M
Lawrence J. Jennings, Maria E
Synthetic Circulating Cell-free DNA as Quality Control Materials for Somatic Mutation Detection in Liquid Biopsy for Cancer R. Zhang, R. Peng, Z. Li, P.
Haley J. Abel, Hussam Al-Kateb, Catherine E. Cottrell, Andrew J
High-Throughput, Multiplex Genotyping Directly from Blood or Dried Blood Spot without DNA Extraction for the Screening of Multiple G6PD Gene Variants.
A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung Cancer  Maruja E. Lira, Yoon-La Choi, Sun Min Lim, Shibing Deng, Donghui.
High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric.
Tiago R. Matos, Menno A. de Rie, Marcel B.M. Teunissen 
Elena Castellanos-Rizaldos, Cloud Paweletz, Chen Song, Geoffrey R
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Volume 38, Issue 4, Pages (May 2010)
Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays 
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Christopher R. Cabanski, Vincent Magrini, Malachi Griffith, Obi L
Genomic alterations in breast cancer cell line MDA-MB-231.
Donavan T. Cheng, Talia N. Mitchell, Ahmet Zehir, Ronak H
CRISPR/Cas9 Technology–Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing  Rongxue Peng, Rui Zhang,
Volume 18, Issue 9, Pages (February 2017)
Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid  Meenakshi Mehrotra, Rajesh.
Volume 54, Issue 1, Pages (April 2014)
Relationship between Genotype and Phenotype
N6-Methyladenosines Modulate A-to-I RNA Editing
Figure 1. Generation of the S250F Aadc mutant mice
Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid  Meenakshi Mehrotra, Rajesh.
Diverse abnormalities manifest in RNA
Supplemental Figure 3 A B C T-DNA 1 2 RGLG1 2329bp 3 T-DNA 1 2 RGLG2
Molecular cloning of pms916 salt hypersensitive T-DNA mutant.
Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer–Related Single-Nucleotide Variants.
Integrative Multi-omic Analysis of Human Platelet eQTLs Reveals Alternative Start Site in Mitofusin 2  Lukas M. Simon, Edward S. Chen, Leonard C. Edelstein,
Joseph Rodriguez, Jerome S. Menet, Michael Rosbash  Molecular Cell 
Alex M. Plocik, Brenton R. Graveley  Molecular Cell 
Figure 1. Plasma next-generation sequencing (NGS) assay workflow, comparison of variant allelic fraction with ... Figure 1. Plasma next-generation sequencing.
CapTCR-seq: hybrid capture for T-cell receptor repertoire profiling
Beth Elliott, Christine Richardson, Maria Jasin  Molecular Cell 
Lawrence J. Jennings, Maria E
Validation of ChIP-seq reads.
A Physical Map, Including a BAC/PAC Clone Contig, of the Williams-Beuren Syndrome– Deletion Region at 7q11.23  Risa Peoples, Yvonne Franke, Yu-Ker Wang,
Complete Haplotype Sequence of the Human Immunoglobulin Heavy-Chain Variable, Diversity, and Joining Genes and Characterization of Allelic and Copy-Number.
Volume 9, Issue 3, Pages (November 2014)
Identification of the CD74–NRG1 fusion gene.
Molecular Therapy - Nucleic Acids
Schematic representation of the SyngenicDNA approach.
CaQTL analysis identifies genetic variants affecting human islet cis-RE use. caQTL analysis identifies genetic variants affecting human islet cis-RE use.
Volume 28, Issue 1, Pages e3 (July 2019)
MicroRNA Binding Sites in Arabidopsis Class III HD-ZIP mRNAs Are Required for Methylation of the Template Chromosome  Ning Bao, Khar-Wai Lye, M.Kathryn.
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off- target Effects in Genome Editing  Ciaran M Lee, Thomas J Cradick,
Figure Genetic characterization of the novel GYG1 gene mutation (A) GYG1_cDNA sequence and position of primers used. Genetic characterization of the novel.
CRISPR Immunological Memory Requires a Host Factor for Specificity
Lawrence J. Jennings, Maria E
Potent and sequence-specific removal through genome targeting with CRISPR-Cas systems. Potent and sequence-specific removal through genome targeting with.
Presentation transcript:

Supplemental Figure 1. Bias-corrected NGS bioinformatics strategies. Paired-end DNA sequencing reveals the sequence of the genomic clone, the sample ID and the unique sequence identifiers in READ_1 and a much shorter READ_2 that determines the probe associated with each clone. The sequence identification tags allow for redundant reads derived from the same original clone to be grouped into sets. By generating consensus unique reads from redundant sets, sequencing errors (red X) are easily identified and removed. True mutation candidates occur when several independent consensus reads all possess the same lesion. The method enriches for sequence information that is 3’ to the capture probe. In cases of opposing probes, regions such as coding exons that are vulnerable to driver mutational events are covered in both orientations. Importantly, the reads from one opposing probe generate sequence coverage of the adjacent probe binding site, providing validation for the probe binding sites used in every experimental sample. For the de novo discovery of gene fusion events, capture probes are tiled across frequently rearranged intronic sequences.

AB Supplemental Figure 2: Comparison of targeted sequencing of cfDNA using standard hybridization selection versus Resolution methods. (A) UCSC genome browser depiction of read coverage in the TP53 vicinity. The coverage track representing hybridization selection of cfDNA was created by mapping the reads from sample SRR of Newman et al The other coverage track represents unique reads from Sample 511 in this paper. The off-target noise outside of the TP53 gene is higher in SRR compared with Sample 511. (B) Genome-wide calculation of off-target versus on-target coverage for the two samples. The percentage of read coverage overlapping the declared target regions (widened by an extra 100 nucleotides on each side) was calculated using bedtools.

Supplemental Figure 3: Sensitivity of mutant allele detection as a function of dilution. A total of four gene fusions and one indel (orange open squares) and thirteen point mutations (black circles) were assayed at varying mutant allele concentrations (Supplemental Table 2). All 18 lesions were detected in the 2.5%, 1.0%, and 0.4% pools, while fourteen out of the 18 were detected at 0.1%. We expect gene fusions to be more difficult to detect because adequate sequence coverage demands a larger assay footprint than point mutations and probe orientation is unidirectional rather than bidirectional. Consistent with this expectation, the ROS1 fusion in cell line HCC78 and the ALK fusion in cell line H3122 were underrepresented.

Supplemental Figure 4: Schematic of predicted genomic junctions for 6 translocations identified in plasma Specimens. 10 RET chr10:43,610, KIF5B chr10:32,316,579 KIF5B – RET